JUL 14, 2019 11:23 AM PDT

Scratching a Chronic Itch

WRITTEN BY: Carmen Leitch

There are many potential reasons why skin might itch, but this annoying condition can significantly impact quality of life when it doesn’t go away. Scientists have had difficulty understanding what causes chronic itch, and while there are theories, there isn’t an effective treatment. New work reported in Science Translational Medicine may help change that.

Nerves that stimulate skin are grouped in structures next to the spinal cord. Here, nerves in such a structure -- called a dorsal root ganglion -- that are involved in detecting an itch are labeled green. Nerves involved in sensing pain, temperature and other stimuli are shown in magenta. / Credit: Hans Juergen Solinski, National Institute of Dental and Craniofacial Research

In previous work, National Institute of Dental and Craniofacial Research (NIDCR) researcher Mark Hoon, Ph.D., and colleagues identified a receptor called Npr1. It was found on nerve cells in mouse spinal cord neurons and binds to a protein that’s been linked to itch. When the Npr1 receptor is bound to the protein, it helps cause the itch sensation. Blocking Npr1 then became a strategy in the search for drugs that can control chronic itch.

to develop drugs from what they identify eventually discover a therapeutic that can block Npr1, and potentially relieve chronic itchiness, researchers at the National Center for Advancing Translational Sciences (NCATS) and the NIDCR used a rapid screening technique to assess 86,000 compounds.

Hoon collaborated with NCATS scientist James Inglese, Ph.D., and his team to screen the molecules. They developed a variety of tests in their effort, and along with robot helpers, they narrowed the pool of potential drugs to about 1,400 compounds. Next, they created a new set of assays to identify the best candidates. A subset of fifteen molecules was eventually shown to stop the Npr1 receptor from functioning in both human and mouse cells. Following up in a mouse model, the scientists found that by block ing Npr1, scratching was reduced.

The investigators are continuing to search for more drugs that can stop Npr1 from binding its target and causing itchiness, and want to eventually develop drugs from what they identify.

"This is a proof-of-concept study and an important application of what NCATS does," Inglese said. "We wanted to show that by pharmacologically blocking the target receptor, the approach could be successful in finding a drug to treat chronic itch. Because it can take a long time to develop an ideal compound, the rationale behind the approach needs to be well-vetted."

Learn more about chronic itch from the video above, and why scratching an itch can make it worse from the following video.

Sources: AAAS/Eurekalert! Via NIH/NCATS, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 26, 2020
Cell & Molecular Biology
JAN 26, 2020
Brains are More Symmetrical in People With Autism
The two halves of the brain and typically assymterical, but that may be less true for individuals with autism spectrum disorder....
JAN 26, 2020
Drug Discovery & Development
JAN 26, 2020
Discovery of mechanism behind Alexander disease may lead to enhanced drug development
Researchers have long known that the cause behind Alexander disease is a genetic culprit—mainly a mutation leading to the production of a defective p...
JAN 26, 2020
Drug Discovery & Development
JAN 26, 2020
Darobactin: Promising New Drug to Combat Antibiotic Resistance
Every year, around 700,000 people are estimated to die from drug-resistant infections thanks to our overuse of antibiotics both in agriculture and medicine...
JAN 26, 2020
Chemistry & Physics
JAN 26, 2020
Wave-Matter Duality Observed on a Biological Macromolecule for the First Time
Quantum physics tells us about the properties and behaviors of particles in the atomic and subatomic world. But scientists have long held the belief that t...
JAN 26, 2020
Microbiology
JAN 26, 2020
A Single-Celled Organism That Seems to Make Choices
A protist has been captured on video 'changing its mind.'...
JAN 26, 2020
Genetics & Genomics
JAN 26, 2020
New Gene Therapy Uses Exosomes to Reverse Disease
Researchers at Ohio State University have developed a new gene therapy that makes use of exosomes, fluid sacs released in cells, to carry therapeutic tools...
Loading Comments...